Cargando…
Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients
BACKGROUND: Bevacizumab has been suggested as a new treatment modality for cerebral radiation necrosis due to its ability to block the effects of vascular endothelial growth factor (VEGF) in leakage-prone capillaries, though its use still remains controversial in clinical practice. METHODS: The use...
Autores principales: | Wang, Yang, Pan, Li, Sheng, Xiaofang, Mao, Yin, Yao, Yu, Wang, Enmin, Zhang, Nan, Dai, Jiazhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493338/ https://www.ncbi.nlm.nih.gov/pubmed/22913802 http://dx.doi.org/10.1186/2047-783X-17-25 |
Ejemplares similares
-
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature
por: Delishaj, Durim, et al.
Publicado: (2017) -
Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab
por: Voss, Martin, et al.
Publicado: (2019) -
A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis
por: Zhuang, Hongqing, et al.
Publicado: (2016) -
Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study
por: Zhuang, Hongqing, et al.
Publicado: (2019) -
Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)